(Q36835021)

English

AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.

scientific article published on November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. (English)

1 reference

Europe PubMed Central

16 August 2017

author name string

Akeson AL

1

1 reference

Europe PubMed Central

16 August 2017

Woods CW

2

1 reference

Europe PubMed Central

16 August 2017

Hsieh LC

3

1 reference

Europe PubMed Central

16 August 2017

Bohnke RA

4

1 reference

Europe PubMed Central

16 August 2017

Ackermann BL

5

1 reference

Europe PubMed Central

16 August 2017

Chan KY

6

1 reference

Europe PubMed Central

16 August 2017

Robinson JL

7

1 reference

Europe PubMed Central

16 August 2017

Yanofsky SD

8

1 reference

Europe PubMed Central

16 August 2017

Jacobs JW

9

1 reference

Europe PubMed Central

16 August 2017

Barrett RW

10

1 reference

Europe PubMed Central

16 August 2017

Bowlin TL

11

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

16 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

16 August 2017

271

1 reference

Europe PubMed Central

16 August 2017

48

1 reference

Europe PubMed Central

16 August 2017

30517-30523

1 reference

Europe PubMed Central

16 August 2017

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Interleukin 1 signaling occurs exclusively via the type I receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Crystallographic refinement of interleukin 1 beta at 2.0 A resolution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Structure of interleukin 1 alpha at 2.7-A resolution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.48.30517

21 January 2018

Identifiers

10.1074/JBC.271.48.30517

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36835021&oldid=1949577129"